Skip to content

Evaluation of the Post-LASIK Flap Thickness of the FS200 Femtosecond Laser Flap

A Single Center Prospective Evaluation of the Post-LASIK Flap Thickness of the FS200 Femtosecond Laser Flap

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01693939
Enrollment
30
Registered
2012-09-26
Start date
2012-02-29
Completion date
2012-04-30
Last updated
2013-01-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia

Keywords

Lasik, Myopia, Femtosecond Laser

Brief summary

The purpose of this study is to document the programmed flap thickness to achieved flap thickness using the FS200 femtosecond laser in performing LASIK procedure. The FS200 Femtosecond laser is a precision surgical device that is used to create a flap in a FDA approved LASIK procedure.

Detailed description

The objective of this study is to evaluate the thickness of the corneal flap created with the FS 200 Femtosecond laser flap during the LASIK procedure using the Visante and OptiVue OCT ultrasound devices.

Interventions

DEVICEFS200 Femtosecond Laser

Sponsors

Alcon Research
CollaboratorINDUSTRY
Durrie Vision
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

The following are requirements for a potential study patient's inclusion into the study: * Male or female in good general health, 18 years of age or older at the time of the pre-operative examination * Patient must be able to read, comprehend and willing to give HIPPA and informed consent * Patient is planning to undergo a bilateral LASIK procedure * Both eyes must have a manifest refractive error from -1.00 to -7.00D spherical equivalent with less than or equal to 3.00 D of refractive astigmatism as expressed in spectacle minus cylinder form * Both eyes must have a BSCVA of 20/25 or better * Both eyes must demonstrate refractive stability confirmed by clinical records or previous glasses. Refractive stability shall be documented by a change of less than or equal to 0.50 diopter per year (sphere and cylinder) or as documented by clinical judgment by the investigator.

Exclusion criteria

The following are

Design outcomes

Primary

MeasureTime frameDescription
Flap Thickness1 Week Postoperative visitThe flap thickness will be measured one week postoperative using the Visante OCT and the Optivue OCT devices

Secondary

MeasureTime frameDescription
Change in Uncorrected Visual Acuity at 1 Day, 1 Week, and 1 Month PostoperativelyPostoperatively 1 monthChange in Uncorrected visual acuity will be measured at 1 Day, 1 week, and 1 month postoperatively

Other

MeasureTime frameDescription
Postoperative Satisfaction Survey over TimePostoperatively Day 1, Week 1, Month 1Subject questionnaire will be administered to evaluate overall patient satisfaction postoperatively

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026